Država: Velika Britanija
Jezik: angleščina
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Naproxen
DE Pharmaceuticals
M01AE02
Naproxen
250mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Naproxen Tablets are and what they are used for 2. What you need to know before you take Naproxen Tablets 3. How to take Naproxen Tablets 4. Possible side effects 5. How to store Naproxen Tablets 6. Contents of the pack and other information 1. WHAT NAPROXEN TABLETS ARE AND WHAT THEY ARE USED FOR Naproxen Tablets contain a medicine called naproxen. This is a 'Non Steroidal Anti Inflammatory Drug' or NSAID. Naproxen Tablets can lessen pain, swelling, redness and heat (inflammation) and is used to treat adults for: • Problems with your muscles, joints and tendons, like strains, gout, ankylosing spondylitis (pain and stiffness in the neck and back) or arthritis. • Women, while having period pain. It can also be used in children over 5 years with rheumatoid arthritis. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NAPROXEN TABLETS DO NOT TAKE NAPROXEN TABLETS • if you are ALLERGIC (hypersensitive) to naproxen or any of the other ingredients of Naproxen Tablets (listed in section 6) • if you are allergic to or have ever had a reaction to ASPIRIN or another NSAID (non- steroidal anti-inflammatory drug) such as ibuprofen, diclofenac or meloxicam • if you have a stomach ulcer or if you often get stomach ulcers • if you have a duodenal ulcer (in the first part of the small intestine) or if you often get duodenal ulcers • if you have serious liver or kidney disease • if you are suffering or have ever suffered from bleeding in the stomach or intestines whil Preberite celoten dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Naproxen 250mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 250mg Naproxen BP Also contains Lactose and Sunset yellow (E110) For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet. Pale yellow, flat bevelled edge tablets with N breakline 250 on one side and BL on the other 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _ _ _ADULTS _ Naproxen is indicated for the treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute gout, acute musculoskeletal disorders and dysmenorrhoea. _CHILDREN _ _ _ Juvenile rheumatoid arthritis 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. To be taken preferably with or after food. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). _ADULTS _ _ _ _RHEUMATOID ARTHRITIS, OSTEOARTHRITIS AND ANKYLOSING SPONDYLITIS _ _ _ The usual dose is 500mg to 1g per day taken in two doses at 12-hour intervals or alternatively, as a single administration. In the following cases a loading dose of 750mg or 1g per day for the acute phase is recommended: 1. In patients reporting severe night-time pain and / or morning stiffness. 2. In patients being switched to naproxen from a high dose of another antirheumatic compound. 3. In osteoarthrosis where pain is the predominant symptom. _ACUTE GOUT _ _ _ The recommended dosage is 750mg at once then 250mg every eight hours until the attack has passed. _ACUTE MUSCULOSKELETAL DISORDERS AND DYSMENORRHOEA _ _ _ The recommended dosage is 500mg initially followed by 250mg at 6 to 8 hour intervals as needed, with a maximum daily dose after the first day of l250mg. _ELDERLY_ Studies indicate that although total plasma concentration of naproxen is unchanged, the unbound plasma fraction of naproxen is increased in the elderly. The implication of this finding for naproxen dosing is unknown. As with Preberite celoten dokument